Thermo Fisher Scientific Net Change in Cash increased by 403.5% to $7.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1348.9%, from -$630.00M to $7.87B. Over 3 years (FY 2021 to FY 2025), Net Change in Cash shows an upward trend with a -0.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.43B | $5.01B | -$7.56B | -$1.71B | -$874.00M | $1.03B | $5.60B | -$5.04B | -$347.00M | $3.02B | -$2.58B | $1.58B | -$2.43B | -$630.00M | $132.00M | $431.00M | -$2.59B | $7.87B |
| QoQ Change | — | +250.1% | -250.7% | +77.3% | +48.9% | +217.7% | +444.5% | -189.9% | +93.1% | +968.9% | -185.5% | +161.2% | -253.8% | +74.0% | +121.0% | +226.5% | -701.4% | +403.5% |
| YoY Change | — | — | — | — | -161.0% | -79.5% | +174.1% | -194.2% | +60.3% | +193.0% | +48.8% | +554.8% | -180.5% | — | +105.1% | -72.7% | -6.8% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.